KR102752089B1 - 저자극성 여성용 청결제 조성물 및 이의 제조 방법 - Google Patents
저자극성 여성용 청결제 조성물 및 이의 제조 방법 Download PDFInfo
- Publication number
- KR102752089B1 KR102752089B1 KR1020240032008A KR20240032008A KR102752089B1 KR 102752089 B1 KR102752089 B1 KR 102752089B1 KR 1020240032008 A KR1020240032008 A KR 1020240032008A KR 20240032008 A KR20240032008 A KR 20240032008A KR 102752089 B1 KR102752089 B1 KR 102752089B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- white rice
- magnolia bark
- flower
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 238000004519 manufacturing process Methods 0.000 title abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 89
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 44
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 44
- 206010020649 Hyperkeratosis Diseases 0.000 claims abstract description 43
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 43
- 240000001548 Camellia japonica Species 0.000 claims abstract description 40
- 241001673966 Magnolia officinalis Species 0.000 claims abstract description 40
- 235000018597 common camellia Nutrition 0.000 claims abstract description 40
- 241000574138 Ozothamnus diosmifolius Species 0.000 claims abstract description 37
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 37
- 235000010659 Phoenix dactylifera Nutrition 0.000 claims abstract description 35
- 239000004480 active ingredient Substances 0.000 claims abstract description 4
- 244000104275 Phoenix dactylifera Species 0.000 claims abstract 2
- 230000000694 effects Effects 0.000 claims description 14
- 230000000774 hypoallergenic effect Effects 0.000 claims description 14
- 241000588724 Escherichia coli Species 0.000 claims description 6
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 6
- 241000191967 Staphylococcus aureus Species 0.000 claims description 6
- 241000222122 Candida albicans Species 0.000 claims description 5
- 229940095731 candida albicans Drugs 0.000 claims description 5
- 229940062851 jujube fruit extract Drugs 0.000 claims description 4
- 230000009036 growth inhibition Effects 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 38
- 241000233805 Phoenix Species 0.000 description 33
- 239000000047 product Substances 0.000 description 23
- 239000002904 solvent Substances 0.000 description 21
- 238000000605 extraction Methods 0.000 description 14
- 239000000843 powder Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 241000186660 Lactobacillus Species 0.000 description 12
- 229940039696 lactobacillus Drugs 0.000 description 12
- 206010040880 Skin irritation Diseases 0.000 description 11
- 239000003599 detergent Substances 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 11
- 230000036556 skin irritation Effects 0.000 description 11
- 231100000475 skin irritation Toxicity 0.000 description 11
- 230000000844 anti-bacterial effect Effects 0.000 description 10
- 210000001215 vagina Anatomy 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 230000001877 deodorizing effect Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000006166 lysate Substances 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 244000068988 Glycine max Species 0.000 description 6
- 235000010469 Glycine max Nutrition 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 231100000344 non-irritating Toxicity 0.000 description 5
- 235000019645 odor Nutrition 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 4
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229940073499 decyl glucoside Drugs 0.000 description 4
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 229940015975 1,2-hexanediol Drugs 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000209094 Oryza Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 206010046914 Vaginal infection Diseases 0.000 description 3
- 201000008100 Vaginitis Diseases 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000004392 genitalia Anatomy 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241001164374 Calyx Species 0.000 description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- -1 cleansers Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 229940051250 hexylene glycol Drugs 0.000 description 2
- 229960004592 isopropanol Drugs 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- KZVAAIRBJJYZOW-VPENINKCSA-N (2r,3r,4s)-2-(hydroxymethyl)oxolane-3,4-diol Chemical compound OC[C@H]1OC[C@H](O)[C@H]1O KZVAAIRBJJYZOW-VPENINKCSA-N 0.000 description 1
- LTBAFRQKFIMYQK-DLWPFLMGSA-N (2s,3r,4r)-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentane-1,2,3,4-tetrol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O LTBAFRQKFIMYQK-DLWPFLMGSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- JJPWJEGNCRGGGA-UHFFFAOYSA-N 4-[[2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]acetyl]amino]benzoic acid Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)NC1=CC=C(C(=O)O)C=C1 JJPWJEGNCRGGGA-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- AJPXZTKPPINUKN-UHFFFAOYSA-N Isoliensinin Natural products C1=CC(OC)=CC=C1CC1C2=CC(OC=3C(=CC=C(CC4C5=CC(O)=C(OC)C=C5CCN4C)C=3)O)=C(OC)C=C2CCN1C AJPXZTKPPINUKN-UHFFFAOYSA-N 0.000 description 1
- AJPXZTKPPINUKN-FIRIVFDPSA-N Isoliensinine Chemical compound C1=CC(OC)=CC=C1C[C@@H]1C2=CC(OC=3C(=CC=C(C[C@@H]4C5=CC(O)=C(OC)C=C5CCN4C)C=3)O)=C(OC)C=C2CCN1C AJPXZTKPPINUKN-FIRIVFDPSA-N 0.000 description 1
- CMHMMKSPYOOVGI-UHFFFAOYSA-N Isopropylparaben Chemical compound CC(C)OC(=O)C1=CC=C(O)C=C1 CMHMMKSPYOOVGI-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 241001247821 Ziziphus Species 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940083987 anhydroxylitol Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 229940047642 disodium cocoamphodiacetate Drugs 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229940113094 isopropylparaben Drugs 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940100573 methylpropanediol Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- RARSHUDCJQSEFJ-UHFFFAOYSA-N p-Hydroxypropiophenone Chemical compound CCC(=O)C1=CC=C(O)C=C1 RARSHUDCJQSEFJ-UHFFFAOYSA-N 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920002620 polyvinyl fluoride Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940080321 sodium anisate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AETSDHMVQHOYPB-UHFFFAOYSA-M sodium;4-methoxybenzoate Chemical compound [Na+].COC1=CC=C(C([O-])=O)C=C1 AETSDHMVQHOYPB-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229940080728 steareth-30 Drugs 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000732 tissue residue Toxicity 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
- A61K2800/72—Hypo-allergenic
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
구분 | 분말(g) |
실시예 1 | 12 |
실시예 2 | 13 |
실시예3 | 14 |
실시예4 | 11 |
실시예5 | 13 |
실시예6 | 17 |
구분 | 추출 용매 | 수득량(g) |
실시예 7 | 30% 함수 에탄올 | 15 |
실시예 8 | 30% 함수 에탄올 | 16 |
실시예 9 | 70% 함수 에탄올 | 19 |
실시예 10 | 80% 함수 에탄올 | 18 |
번호 (No.) |
원료(Ingredients) | 함량 (중량 wt, %) |
1 | 백미꽃추출물, 목련나무껍질추출물, 대추야자열매, 동백마무캘러스추출물, 연꽃꽃추출물(실시예 9) | 1.0 |
2 | 정제수(water) | 잔량 |
3 | 다이소듐코코암포다이아세테이트(Disodium Cocoamphodiacetate) | 10.0 |
4 | 데실글루코사이드(Decyl Glucoside) | 20.0 |
5 | 소듐크로라이드(Sodium Chloride) | 1.0 |
6 | 1,2-헥산다이올(1,2-Hexanediol) | 2.0 |
7 | 알란토인(Allantoin) | 1.0 |
8 | 베타인(Betaine) | 3.0 |
9 | 트레할로오스(Trehalose) | 3.0 |
10 | 락토바실러스/콩발효추출물(Lactobacillus/Soybean Ferment Extract) | 1.0 |
11 | 락토바실러스발효용해물(Lactobacillus Ferment Lysate) | 1.0 |
12 | 스트렙토코쿠스 테르모필루스 발효물(Streptococcus Thermophilus Ferment) | 1.0 |
13 | 비피다발효용해물(Bifida Ferment Lysate) | 1.0 |
14 | 자이리틸글루코사이드(Xylitylglucoside) | 3.0 |
15 | 안하이드로자이리톨(Anhydroxylitol) | 3.0 |
16 | 자이리톨(Xylitol) | 1.0 |
17 | 글루코오스(Glucose) | 1.0 |
18 | 판테놀(Panthenol) | 3.0 |
19 | 헥실렌글라이콜(Hexylene Glycol) | 1.0 |
20 | 펜틸렌글라이콜(Pentylene Glycol) | 3.0 |
21 | 글리세린(Glycerin) | 3.0 |
22 | 하이드로제네이티드레시틴(Hydrogenated Lecithin) | 3.0 |
23 | 세라마이드엔피(Ceramide NP) | 1.0 |
24 | 부틸렌글라이콜(Butylene Glycol) | 1.0 |
25 | 메틸프로판다이올(Methylpropanediol) | 3.0 |
26 | 카프릴릴글라이콜(Caprylyl Glycol) | 3.0 |
27 | 에틸헥실글리세린(Ethylhexylglycerin) | 3.0 |
28 | 스테아레스-28(Steareth-30) | 3.0 |
29 | 클로헥시딘다이글루코네이트(Chlorhexidine Digluconate) | 미량 |
30 | 시트릭애씨드(Citric Acid) | 1.0 |
31 | 다이소듐이디티에이(Disodium EDTA) | 1.0 |
총량(Total, %) | 100 |
시험항목 | 초기농도 (CFU/mL) |
24시간후 농도(CFU/mL) |
정균감소율(%) | 살균감소율(%) | |
대장균 | BLANK | 5.8 × 104 | 2.7 × 107 | - | - |
제조예 | 5.8 × 104 | < 10 | 99.9 | 99.9 | |
녹농균 | BLANK | 5.8 × 104 | 7.9 × 107 | - | - |
제조예 | 5.8 × 104 | < 10 | 99.9 | 99.9 | |
황색포도상구균 | BLANK | 5.0 × 104 | 1.8 × 107 | - | - |
제조예 | 5.0 × 104 | < 10 | 99.9 | 99.9 | |
칸디다균 | BLANK | 6.1 × 104 | 1.7 × 108 | - | - |
제조예 | 6.1 × 104 | < 10 | 99.9 | 99.9 | |
-시험환경: (37.0 ± 0.4) °C -감소율(%) 계산 정균감소율(%) = B-C/B*100 살균감소율(%) = A-C/A*100 (A: 초기 BLANK 농도, B: 24시간 후 BLANK 농도 C: 24시간 후 시험 시료 농도) -CFU: Colony Forming Unit -반응시간: 24시간 |
시험항목(%) | 시험결과 |
암모니아(농도감소율%) | 93.3 |
트리메틸아민(농도감소율%) | 97.5 |
기호 | 점수 | 설명 |
- | 0 | 반응 없음 |
+ | 1 | 약하지만 뚜렷하게 보이는 홍반 반응 |
++ | 2 | 뚜렷한 홍반이 보이며 구진 혹은 부종을 동반한 홍반 반응 |
+++ | 3 | 부종 및 구진을 동반한 강한 홍반 반응 |
++++ | 4 | 부종과 수포를 동반한 강한 홍반 반응 |
피부 자극 지수 | 피부 자극도 판정 |
0.00 ~ 0.25 | 비(무) 자극성(Excellent) |
0.26 ~ 1.00 | 약한 자극성(Good) |
1.01 ~ 2.50 | 중증도 자극성(Bad) |
2.51 ~ 4.00 | 강한 자극성(Very Bad) |
실시예 9 | 30min | 24hrs | 평균피부반응도 | 판정결과 | ||||||
1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 | |||
- | - | - | - | - | - | - | - | 0.00 | 비자극(Excellent) |
Claims (3)
- 백미꽃추출물, 목련나무껍질추출물, 대추야자열매추출물, 동백나무캘러스추출물 및 연꽃꽃추출물을 유효성분으로 포함하되,
상기 백미꽃추출물, 목련나무껍질추출물, 대추야자열매추출물, 동백나무캘러스추출물 및 연꽃꽃추출물은 각각 1:1:1:1:1의 건조 중량비로 혼합되어 추출된 것임을 특징으로 하는 저자극성 여성용 청결제 조성물.
- 제 1항에 있어서, 상기 백미꽃추출물, 목련나무껍질추출물, 대추야자열매추출물, 동백나무캘러스추출물 및 연꽃꽃추출물은 대장균(Escherichia coli), 녹농균(Pseudomonas aeruginosa), 황색포도상구균(Staphylococcus aureus) 및 칸디다균(Candida albicans)의 생장 억제 활성을 가지는 것을 특징으로 하는 저자극성 여성용 청결제 조성물.
- 제 1항에 있어서, 상기 여성용 청결제는 pH가 4.5 내지 6.0인 것을 특징으로 하는 저자극성 여성용 청결제 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020240032008A KR102752089B1 (ko) | 2024-03-06 | 2024-03-06 | 저자극성 여성용 청결제 조성물 및 이의 제조 방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020240032008A KR102752089B1 (ko) | 2024-03-06 | 2024-03-06 | 저자극성 여성용 청결제 조성물 및 이의 제조 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102752089B1 true KR102752089B1 (ko) | 2025-01-09 |
Family
ID=94237773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020240032008A Active KR102752089B1 (ko) | 2024-03-06 | 2024-03-06 | 저자극성 여성용 청결제 조성물 및 이의 제조 방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102752089B1 (ko) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170036829A (ko) * | 2015-09-18 | 2017-04-03 | 주식회사 바이오에프디엔씨 | 동백 식물 세포 배양 추출물을 함유한 항노화 피부 외용제 조성물 및 그 제조방법 |
KR20180087764A (ko) * | 2017-01-25 | 2018-08-02 | 주식회사 아미코스메틱 | 감자 추출물 또는 감자박 추출물을 포함하는 여성 청결제 조성물 |
KR102069297B1 (ko) | 2019-07-26 | 2020-01-22 | 이길재 | 여성 청결제 조성물 |
KR102133101B1 (ko) | 2018-11-27 | 2020-07-10 | 소현미 | 백모화 및 쑥을 함유하는 여성청결제 조성물 |
KR102296688B1 (ko) | 2020-08-03 | 2021-08-31 | 박종호 | 천연물 유래의 질 건강 유지용 조성물 |
KR20230033519A (ko) * | 2021-09-01 | 2023-03-08 | 주식회사 파마칼 인터내셔널 | 인체 줄기 세포 배양액을 함유한 여성 청결제 조성물 |
KR102575660B1 (ko) | 2021-03-30 | 2023-09-06 | 신미영 | 항균 활성을 갖는 외용제용 조성물을 포함하는 여성 청결제 |
-
2024
- 2024-03-06 KR KR1020240032008A patent/KR102752089B1/ko active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170036829A (ko) * | 2015-09-18 | 2017-04-03 | 주식회사 바이오에프디엔씨 | 동백 식물 세포 배양 추출물을 함유한 항노화 피부 외용제 조성물 및 그 제조방법 |
KR20180087764A (ko) * | 2017-01-25 | 2018-08-02 | 주식회사 아미코스메틱 | 감자 추출물 또는 감자박 추출물을 포함하는 여성 청결제 조성물 |
KR102133101B1 (ko) | 2018-11-27 | 2020-07-10 | 소현미 | 백모화 및 쑥을 함유하는 여성청결제 조성물 |
KR102069297B1 (ko) | 2019-07-26 | 2020-01-22 | 이길재 | 여성 청결제 조성물 |
KR102296688B1 (ko) | 2020-08-03 | 2021-08-31 | 박종호 | 천연물 유래의 질 건강 유지용 조성물 |
KR102575660B1 (ko) | 2021-03-30 | 2023-09-06 | 신미영 | 항균 활성을 갖는 외용제용 조성물을 포함하는 여성 청결제 |
KR20230033519A (ko) * | 2021-09-01 | 2023-03-08 | 주식회사 파마칼 인터내셔널 | 인체 줄기 세포 배양액을 함유한 여성 청결제 조성물 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101345709B1 (ko) | 질염의 예방 또는 치료에 효과가 있는 항균제 조성물과 이를 포함하는 여성용 청결제 조성물 | |
KR102069297B1 (ko) | 여성 청결제 조성물 | |
KR101870780B1 (ko) | 다마스크 장미꽃오일 및 프로폴리스 추출물을 유효성분으로 포함하는 여성용 청결제 조성물 | |
KR102133101B1 (ko) | 백모화 및 쑥을 함유하는 여성청결제 조성물 | |
KR102296688B1 (ko) | 천연물 유래의 질 건강 유지용 조성물 | |
KR101393007B1 (ko) | 람부탄 및 리치 추출물을 유효성분으로 함유하는 피부노화방지용 및 피부주름 개선용 화장료 조성물 | |
JP2021509410A (ja) | モリンガ・オレイフェラ種子のタンパク質抽出物の美容的使用 | |
KR102373422B1 (ko) | 기능성 펩타이드를 포함하는 질 세정용 조성물 | |
KR102047214B1 (ko) | 두피 관리용 조성물 및 이의 제조방법 | |
KR20160015718A (ko) | 쇠비름 추출물 및 피톤치드를 함유하는 여성 청결제 | |
KR102450505B1 (ko) | 무화과 효소 및 아연 혼합물을 포함하는 친환경 비건 남성 청결제 | |
KR102575660B1 (ko) | 항균 활성을 갖는 외용제용 조성물을 포함하는 여성 청결제 | |
CN108203631A (zh) | 一种抑菌清洁产品及其制备方法 | |
KR102148808B1 (ko) | 천연 항균제를 포함하는 여성청결제 조성물 | |
KR102695884B1 (ko) | 화산송이를 이용한 식물 추출 발효물 및 이를 함유하는 화장료 조성물 | |
KR101963597B1 (ko) | 접시꽃 캘러스 추출물 또는 수정목 캘러스 추출물을 유효성분으로 포함하는 항산화, 미백 및 보습용 화장료 조성물 | |
KR102752089B1 (ko) | 저자극성 여성용 청결제 조성물 및 이의 제조 방법 | |
CA1269938A (en) | Cosmetic compositions having skin calming and skin regenerating effect and process for the preparation thereof | |
CN108531319A (zh) | 一种抑菌清洁产品及其制备方法 | |
KR101581706B1 (ko) | 고사리 열수추출물 발효액을 함유하는 화장료 조성물 및 이의 제조방법 | |
KR20200093154A (ko) | 한방 여성청결제 | |
KR20110032715A (ko) | 노화방지 화장료 조성물 및 그 제조방법 | |
KR102413425B1 (ko) | 베타글루칸을 포함하는 여성 청결제용 조성물 및 이를 포함하는 진공 충진 앰플 | |
KR102159826B1 (ko) | 탈염 미네랄 용암해수로 재배한 작약 추출물을 포함하는 항균용 조성물 및 이의 제조 방법 | |
KR101427027B1 (ko) | 모과 캘러스 추출물을 함유한 피부외용제 조성물 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20240306 |
|
PA0201 | Request for examination |
Patent event code: PA02011R01I Patent event date: 20240306 Comment text: Patent Application |
|
PA0302 | Request for accelerated examination |
Patent event date: 20240307 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination |
|
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20240520 Patent event code: PE09021S01D |
|
PE0902 | Notice of grounds for rejection |
Comment text: Final Notice of Reason for Refusal Patent event date: 20240626 Patent event code: PE09021S02D |
|
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20241112 Comment text: Decision to Refuse Application Patent event code: PE06012S01D |
|
AMND | Amendment | ||
PX0901 | Re-examination |
Patent event code: PX09012R01I Patent event date: 20241204 Comment text: Amendment to Specification, etc. |
|
PX0701 | Decision of registration after re-examination |
Patent event date: 20241212 Comment text: Decision to Grant Registration Patent event code: PX07013S01D |
|
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20250103 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20250103 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration |